12:00 AM
 | 
Jul 03, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Radiolabeled MH1 Fab' fragment of a monoclonal antibody targeted to fibrin in clots regulatory update

MABA received U.S. Patent No. 6,080,384 covering methods and compositions related to radiolabeling sulfhydryl group-bearing biomolecules for imaging human...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >